Entera Bio Ltd.
ENTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,200 | -$2,656 | -$2,567 | -$2,358 |
| Dep. & Amort. | $8 | $7 | $8 | $11 |
| Deferred Tax | $0 | $0 | $0 | $14 |
| Stock-Based Comp. | $0 | $0 | $604 | $566 |
| Change in WC | -$178 | $492 | $555 | $295 |
| Other Non-Cash | $630 | $511 | -$4 | $5 |
| Operating Cash Flow | -$2,740 | -$1,646 | -$1,404 | -$1,467 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$46 | -$29 | -$8 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$46 | -$29 | -$8 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $804 | $13 | $13,337 | $3,359 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$142 |
| Financing Cash Flow | $804 | $13 | $13,337 | $3,217 |
| Forex Effect | -$288 | -$38 | -$12 | $0 |
| Net Chg. in Cash | -$2,271 | -$1,700 | $11,913 | $1,747 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,873 | $20,573 | $8,660 | $6,993 |
| End Cash | $16,602 | $18,873 | $20,573 | $8,740 |
| Free Cash Flow | -$2,787 | -$1,675 | -$1,412 | -$1,470 |